Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy.

Romero-Sánchez MC, Alvarez-Ríos AI, Bernal-Morell E, Genebat M, Vera F, Benhnia MR, Bravo-Urbieta J, Galera-Peñaranda C, de Pablo-Bernal RS, Abad-Carrillo MA, Leal M, Ruiz-Mateos E; VIH-GEMUVIH Región de Murcia Study Group.

Antiviral Res. 2014 Nov;111:26-32. doi: 10.1016/j.antiviral.2014.08.011. Epub 2014 Aug 27.

PMID:
25173576
2.

[Sepsis shock and respiratory distress during boutonneuse fever in a HIV infected patient].

García Noguera D, Galera Peñaranda C, Poza Cisneros G, Oteo Revuelta JA.

Med Clin (Barc). 2011 Feb 19;136(4):175-6. doi: 10.1016/j.medcli.2009.11.016. Epub 2010 Jan 21. Spanish. No abstract available.

PMID:
20096424
3.

Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.

Pineda JA, González J, Ortega E, Tural C, Macías J, Griffa L, Burgos A; Grafihco Study Team.

J Viral Hepat. 2010 Oct;17(10):714-9. doi: 10.1111/j.1365-2893.2009.01229.x.

PMID:
20002560
4.

Duodenal leishmaniasis in a HIV patient.

Egea Valenzuela J, Baños Madrid R, Rodrigo Agudo JL, Galera Peñaranda C, Torroba A, Molina Martínez J, Carballo Alvarez F.

Rev Esp Enferm Dig. 2009 Jan;101(1):60-2. English, Spanish. No abstract available.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk